An increase in the expression of MARCKS was also observed in leukemia cells showing acquired resistance to other second-generation proteasomal inhibitors including, Salinosporamide A (Marizomib) and the immunoproteasome inhibitor PR924. Here, MARCKS is linked to leukemia.